All VRC01 articles
-
NewsAnti-HIV antibody clinical trials offer clues to prevent viral escape and resistance
The broadly neutralizing antibody VRC01 has been thoroughly vetted as a potential prophylactic that could prevent people from becoming infected with HIV. A new analysis of data shows that the antibody initially provides strong protection, but that some strains of the virus can still cause breakthrough infections after treatment has stopped.